Concepedia

Andrew W. Hahn

AW

Statistics

Publications

45

Citations

1.6K

H-Index

24

Active since

2006

Affiliations

University of Utah(Current)

Huntsman Cancer Institute

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Emory University

Andrew W. Hahn is an author at University of Utah specializing in medicine, oncology, and renal cell carcinoma.

Publications per year

2006–2025

45

Publications

45

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

Nieves Martínez Chanzá, Wanling Xie, Mehmet Asım Bilen et al. · The Lancet Oncology · 2019 · 175 citations

Medicine, Oncology, Pharmacology +11

Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA

Neeraj Agarwal, Sumanta K. Pal, Andrew W. Hahn et al. · Cancer · 2018 · 101 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer

Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig et al. · European Urology · 2020 · 77 citations · Full text

Medicine, Oncology, Urology +10

Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma

Junjie Ma, James A. Kuzman, Abhijit Ray et al. · Scientific Reports · 2018 · 76 citations · Full text

Medicine, Immunology, Oncology +15

PD-1 checkpoint inhibition: Toxicities and management

Andrew W. Hahn, David Gill, Neeraj Agarwal et al. · Urologic Oncology Seminars and Original Investigations · 2017 · 68 citations

Medicine, Oncology, Pharmacology +12

1–5 of 45